Literature DB >> 3671330

The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro.

T Godfraind1, C Eglème, M Finet, P Jaumin.   

Abstract

We have studied the action of nifedipine and nisoldipine on the contractile activity of human isolated coronary arteries and human isolated auricular and ventricular muscles. Nisoldipine depressed dose dependently the spontaneous rhythmic contractions displayed by the coronary artery preparations and at 1 nM abolished these contractions. Nisoldipine was twenty times more potent than nifedipine as an inhibitor of increase in tone induced by depolarization (100 mM K+). The rhythmic activity induced by serotonin (10 microM) was about five times more sensitive to nisoldipine than to nifedipine. In both auricular and ventricular preparations, isoprenaline evoked an increase in the rate of force development and in the rate of relaxation. Nifedipine was five times (ventricular muscles) and ten times (auricular muscles) more potent than nisoldipine as a negative inotropic agent. The present observations in human isolated preparations indicate that nisoldipine shows a higher vascular selectivity than nifedipine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3671330     DOI: 10.1111/j.1600-0773.1987.tb01779.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  11 in total

1.  The influence of 3-ester side chain variation on the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries.

Authors:  G Kojda; W Klaus; G Werner; U Fricke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

2.  Vasodilatory effects of nisoldipine on coronary arteries--correlation with plasma levels.

Authors:  S Jost; W Rafflenbeul; B Mogwitz; D Gulba; H Hecker; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 3.  Combination therapy with calcium-entry blockers and beta-adrenoceptor antagonists in hypertension.

Authors:  P Sever
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 4.  Towards chamber specific heart-on-a-chip for drug testing applications.

Authors:  Yimu Zhao; Naimeh Rafatian; Erika Yan Wang; Qinghua Wu; Benjamin F L Lai; Rick Xingze Lu; Houman Savoji; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2020-01-07       Impact factor: 15.470

Review 5.  Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.

Authors:  H D Langtry; C M Spencer
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 6.  Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 7.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

8.  Intervascular and stimulus selectivity of nitrendipine and related derivatives in KCl and prostaglandin F2 alpha precontracted porcine arteries.

Authors:  G Kojda; W Klaus; G Werner; U Fricke
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.

Authors:  G Werner; W Klaus; G Kojda; U Fricke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

10.  1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.

Authors:  Mauro Cataldi; Fiorentina Bruno
Journal:  Transl Med UniSa       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.